mobile mobile

Invagen.com

Website Analysis

GENERAL INFO icon
Website Age
20 years, 6 months ago
Alexa Rank
None
IP Address
None
META INFORMATION icon
Title
Leading Pharmaceutical Company in USA | Cipla USA Inc.
Description
Cipla USA Inc. - One of the leading pharmaceutical companies in USA with over 1500 products with 60 plus dosage forms. US FDA approved since 1984.
Content Type
utf-8
Top Similar websites icon
Domain Rank Visitors Earning per month Valuation
ciplausa.com 9274262 174 32$ 960$
cipla.com 222109 3,494 650$ 19500$
cipla.co.za 2155952 938 87$ 2610$
dakdrug.com 2107687 34 13$ 390$
ciplahealth.in 1004687 97 27$ 810$
cofsils.com 1468326 699 65$ 1950$
immunoboosters.in None 0 0$ 1000$
dailycalcium.in None 0 0$ 1000$
Countries
Country Rank Pct
Alexa rank
Country Name Unknown
Daily unique visits 0
Daily Page Views 0
Income Per Day 0 USD
Invagen.com valuation 1000
GENERAL HTML INFORMATION icon
Type Status
HTML 5 img
Responsive Website img
HTML SIZE INFORMATION icon
Invagen.com has a website text/code ratio of 21 %. Search engine crawlers tend to not pick up pages with inadequate content.
  • HTML Size: 668 KB
  • Text Size: 14028 KB
  • Code Size: 52772 KB
IMPORTANT HTML TAGS AND COUNTS icon
  • H10
  • H21
  • H321
  • H41
  • H50
  • H60
H2
No Text
1 Patients / Physicians / Pharmacists
H3
No Text
1 Alendronate 35 mg
2 Amlodipine 2.5 mg
3 Amlodipine 5 mg
4 Amlodipine 10 mg
5 Doxycycline 50 mg
6 Famciclovir
7 Ipratropium Albuterol
8 Lamotrigine 25 mg
9 Lamotrigine 100 mg
10 Lamotrigine 150 mg
11 Lamotrigine 200 mg
12 Meloxicam 15 mg
13 Meloxicam 7.5 mg
14 Rizatriptan 5 mg
15 Rizatriptan 10 mg
16 Topiramate 25 mg
17 Topiramate 50 mg
18 Topiramate 100 mg
19 Topiramate 200 mg
20 Valacyclovir 1 gm
21 Valacyclovir 500 mg
H4
No Text
1 866-604-3268
COLOR ANALYSIS icon
  • #D03C98
  • #7B5A67
  • #F24451
  • #9D9033
  • #03B34A
  • #164731
  • #84DCC6
  • #DAED97
  • #D5EBB4
SOCIAL NETWORKS icon
Social Count
Facebook Likes 0
Reddit score 0
Pinterest Share Count 0
Vk Share Count 0
OK Share Count 0
COMMENTS (0)

POST A COMMENT